What is Congenital Myotonic Dystrophy (CDM)? Explained
At a Glance
Congenital myotonic dystrophy (CDM) is the most severe form of myotonic dystrophy type 1, present from birth. It causes profound muscle weakness, breathing issues, and feeding difficulties. Inherited almost exclusively from the mother, it requires immediate NICU care and long-term medical support.
In this answer
4 sections
Congenital myotonic dystrophy (CDM) is the most severe form of myotonic dystrophy type 1 (DM1) [1][2]. “Congenital” means the condition is present from birth. Unlike adult-onset forms of DM1 where symptoms develop gradually, babies born with CDM experience immediate, life-threatening symptoms [3][4]. The condition profoundly affects muscle development and function in the womb and immediately after birth, requiring intensive medical care [5][6].
Although the disease is called “myotonic” dystrophy, babies with CDM generally do not have myotonia (an inability to quickly relax muscles after using them) at birth; instead, myotonia typically develops later in childhood [7].
What Does CDM Look Like at Birth?
The symptoms of CDM are often noticeable during pregnancy. Mothers may experience reduced fetal movement or polyhydramnios (an excess of amniotic fluid around the baby because the baby is not swallowing normally in the womb) [3][5][8].
At birth, the three most critical challenges for a baby with CDM are:
- Profound muscle weakness (Severe hypotonia): Babies with CDM are born with extremely weak, low muscle tone. This is often referred to by doctors as “floppy infant syndrome” because the baby lacks the strength to move or support their own body [5][6][9].
- Breathing difficulties: Because the chest and diaphragm muscles are incredibly weak, babies often cannot breathe effectively on their own and typically require immediate respiratory support, such as a ventilator [5][10][11].
- Feeding issues: Muscle weakness in the face and throat prevents normal sucking and swallowing [9][5]. Nutritional support, often through a feeding tube, is usually required to ensure the baby gets adequate nourishment safely without inhaling milk into their lungs [11][12].
Why is it the Most Severe Form?
To understand CDM, it helps to understand how myotonic dystrophy is caused. DM1 is caused by an expansion of a repeating DNA sequence (known as CTG repeats) in the DMPK gene [1][2]. Healthy individuals have a small number of these repeats, but people with DM1 have an abnormally high number. This creates toxic RNA molecules that interfere with normal cell functions [13][14].
In general, the higher the number of repeats, the more severe the symptoms [15][16]. While an adult with mild DM1 might have 50 to 150 repeats, babies with CDM almost always have massive repeat expansions, often exceeding 1,000 repeats [1][2]. This extremely high repeat length is what causes the symptoms to present so severely at birth [15][16].
Maternal Inheritance and Genetic Anticipation
CDM is almost exclusively inherited from an affected mother [17][3][4]. This occurs due to a phenomenon called genetic anticipation, where the number of DNA repeats can expand and grow significantly larger as the gene is passed from parent to child [18][19].
During the process of egg cell formation in a mother who has DM1, the repeat sequence is highly unstable and can rapidly multiply [3][4]. A mother with very mild or even completely undiagnosed DM1 can pass on a massively expanded gene to her baby, resulting in CDM [17][16].
Important Note for Mothers: If your baby is diagnosed with CDM, it generally means that you, as the biological mother, also have DM1. Receiving a dual diagnosis for both your newborn and yourself is incredibly overwhelming, but it is critical that you seek your own medical evaluation. Mothers should be evaluated by a neurologist and a cardiologist, as DM1 requires its own monitoring and care [4][10].
Long-Term Outlook and Care
Hearing a CDM diagnosis in the NICU is devastating and frightening. The immediate goal for a baby born with CDM is ensuring they can breathe and receive adequate nutrition [10][11]. It is important to know that with modern neonatal intensive care, a significant majority of these infants survive the critical newborn period, and their life-threatening breathing issues often slowly improve over time [10].
As children with CDM grow, they face significant long-term developmental challenges. These often include intellectual disabilities, autism spectrum traits, cognitive deficits, and persistent physical challenges with motor function and facial muscles [20][21][22]. Managing these complex needs requires a multi-disciplinary medical team—including neurologists, pulmonologists, feeding specialists, and physical/developmental therapists—to support the child and help them reach their fullest potential [10][11].
Common questions in this guide
How is congenital myotonic dystrophy different from regular DM1?
Why do babies with congenital myotonic dystrophy need a feeding tube?
How do babies inherit congenital myotonic dystrophy?
What is the long-term outlook for a baby with CDM?
Does the mother of a baby with CDM need medical care?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What are the specific milestones my baby needs to meet to safely begin weaning off the ventilator or respiratory support?
- 2.What are our long-term feeding options, and how will the team evaluate if my baby is ready to try feeding by mouth?
- 3.Who will be responsible for coordinating my baby's multidisciplinary care team (neurology, pulmonology, feeding therapy) once we are discharged from the NICU?
- 4.Can you refer us to a genetic counselor to help us understand my baby's exact CTG repeat count and the implications for our family?
- 5.Since this diagnosis means the birth mother likely has DM1, what specific specialists (such as a cardiologist or neurologist) should she see immediately for her own health evaluation?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (22)
- 1
Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1.
Sharp L, Cox DC, Cooper TA
Muscle & nerve 2019; (60(6)):779-789 doi:10.1002/mus.26709.
PMID: 31509256 - 2
Corpus Callosum Diffusion Restriction in Neonatal Congenital Myotonic Dystrophy.
Sakatani N, Ikeda H, Inami Y, et al.
Cureus 2025; (17(10)):e94776 doi:10.7759/cureus.94776.
PMID: 41250692 - 3
Congenital myotonic dystrophy: An overlooked diagnosis not amenable to detection by sequencing.
Rogers R, Moyer K, Moise KJ
Prenatal diagnosis 2022; (42(2)):233-235 doi:10.1002/pd.6105.
PMID: 35083764 - 4
Case report of congenital myotonic dystrophy with multiple prenatal sonographic findings.
Strelcovienė Z, Machtejevienė E, Minkauskienė M, Traberg R
Case reports in perinatal medicine 2024; (13(1)):20230029 doi:10.1515/crpm-2023-0029.
PMID: 40321342 - 5
Neonatal congenital myotonic dystrophy with DMPK gene expansion: clinical features and short-term outcomes.
Zhao Q, Wang S, Wang Y, Ding S
Frontiers in pediatrics 2025; (13()):1648611 doi:10.3389/fped.2025.1648611.
PMID: 41585019 - 6
Infection-Induced Rhabdomyolysis in a Pregnant Woman with Undiagnosed Myotonic Dystrophy: A Case Report.
Kim HM, Kim H, Cha HH, et al.
Medicina (Kaunas, Lithuania) 2023; (59(5)) doi:10.3390/medicina59050824.
PMID: 37241056 - 7
The blind men and the elephant: recognising the multisystem symptoms of myotonic dystrophy type 1.
Leeuwenberg KE, Bruijnes JE, Karnebeek L, et al.
Orphanet journal of rare diseases 2025; (20(1)):427 doi:10.1186/s13023-025-03920-z.
PMID: 40804685 - 8
Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy.
Yee C, Choi SJ, Oh SY, et al.
Obstetrics & gynecology science 2017; (60(4)):323-328 doi:10.5468/ogs.2017.60.4.323.
PMID: 28791262 - 9
Prenatal, Neonatal, and Early Childhood Features in Congenital Myotonic Dystrophy.
Zapata-Aldana E, Ceballos-Sáenz D, Hicks R, Campbell C
Journal of neuromuscular diseases 2018; (5(3)):331-340 doi:10.3233/JND-170277.
PMID: 30010141 - 10
Myotonic Dystrophy.
Perez PG
Continuum (Minneapolis, Minn.) 2025; (31(5)):1437-1461 doi:10.1212/cont.0000000000001621.
PMID: 41037177 - 11
Congenital Myotonic Dystrophy and Brugada Syndrome: A Report of Two Cases.
Gupta K, Kennelly MR, Siddappa AM
The American journal of case reports 2020; (21()):e919867 doi:10.12659/AJCR.919867.
PMID: 31915326 - 12
Respiratory dysfunction in myotonic dystrophy type 1: A systematic review.
Hawkins AM, Hawkins CL, Abdul Razak K, et al.
Neuromuscular disorders : NMD 2019; (29(3)):198-212 doi:10.1016/j.nmd.2018.12.002.
PMID: 30765255 - 13
Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
Michel L, Huguet-Lachon A, Gourdon G
PloS one 2015; (10(9)):e0137620 doi:10.1371/journal.pone.0137620.
PMID: 26339785 - 14
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy.
Thomas JD, Sznajder ŁJ, Bardhi O, et al.
Genes & development 2017; (31(11)):1122-1133 doi:10.1101/gad.300590.117.
PMID: 28698297 - 15
Impact of prematurity and the CTG repeat length on outcomes in congenital myotonic dystrophy.
Saito Y, Matsumura K, Kageyama M, et al.
BMC research notes 2020; (13(1)):350 doi:10.1186/s13104-020-05186-z.
PMID: 32703309 - 16
Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent.
Morales F, Corrales E, Zhang B, et al.
Human molecular genetics 2021; (31(2)):262-274 doi:10.1093/hmg/ddab243.
PMID: 34432028 - 17
[Beyond premature apnea pauses: congenital myotonic dystrophy type 1].
Del Olmo Segura P, Solé Delgado C, Martínez Del Val E
Andes pediatrica : revista Chilena de pediatria 2024; (95(5)):608-612 doi:10.32641/andespediatr.v95i5.5092.
PMID: 39760631 - 18
Clinical and genetic characteristics of childhood-onset myotonic dystrophy.
Stokes M, Varughese N, Iannaccone S, Castro D
Muscle & nerve 2019; (60(6)):732-738 doi:10.1002/mus.26716.
PMID: 31520483 - 19
Mosaicism in Short Tandem Repeat Disorders: A Clinical Perspective.
Doss RM, Lopez-Ignacio S, Dischler A, et al.
Genes 2025; (16(2)) doi:10.3390/genes16020216.
PMID: 40004546 - 20
Relative risks for comorbidities associated with myotonic dystrophy: A population-based analysis.
Johnson NE, Abbott D, Cannon-Albright LA
Muscle & nerve 2015; (52(4)):659-61 doi:10.1002/mus.24766.
PMID: 26172955 - 21
Association between Reported Sleep Disorders and Behavioral Issues in Children with Myotonic Dystrophy Type 1-Results from a Retrospective Analysis in Italy.
Trucco F, Lizio A, Roma E, et al.
Journal of clinical medicine 2024; (13(18)) doi:10.3390/jcm13185459.
PMID: 39336946 - 22
Neurobehavioral Phenotype of Children With Congenital Myotonic Dystrophy.
Patel N, Berggren KN, Hung M, et al.
Neurology 2024; (102(5)):e208115 doi:10.1212/WNL.0000000000208115.
PMID: 38359368
This page provides educational information about congenital myotonic dystrophy (CDM). It does not replace professional medical advice, diagnosis, or treatment from your pediatric neurologist or neonatologist.
Get notified when new evidence is published on Myotonic dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.